Early Stage Clinical

First-in-Human Clinical Trials - QPS Provides Critical Drug Development Data Quickly, Accurately and Cost Effectively - May, 2013

Accurate and timely data is imperative for success at every stage of drug discovery and development. Equally important is the ability to shorten the drug development timeline and decision making process. QPS provides state-of-the-art facilities for conducting First-in-Human (FIH) clinical trials in both healthy volunteers and patients, and boasts one of the world’s largest Phase I site offerings with 500 beds on three continents: Europe, Asia and North America. Our protocols and linearly integrated preclinical and clinical drug development resources and services enable us to provide critical data from FIH studies quickly, accurately, and cost effectively. Our studies validate uses for investigational products and provide invaluable safety and efficacy data. QPS’ leading capability in conducting high quality early and late phase studies, combined with established expertise in bioanalysis, translational medicine, and pharmacometrics services, make QPS your ideal First-in-Human clinical trial partner.

To find out more about testing your developmental compound and speeding its progress from First-in-Human to successful Proof-of-Concept through QPS’ integrated Early Stage Clinical Research services, please click on the link below:

20 years in pharma R&D navigation